Sol_75N98026Q01140.pdf

REQUEST FOR QUOTATION

(THIS IS NOT AN ORDER)

THIS RFQ IS IS NOT A SMALL BUSINESS SET-ASIDE

15. DATE OF QUOTATION

16. SIGNER

a. NAME (Type or print)

c. TITLE (Type or print)

b. TELEPHONE

AREA CODE

NUMBER

STANDARD FORM 18 (REV. 6/1995)

Prescribed by GSA-FAR (48 CFR) 53.215-1(a)

AUTHORIZED FOR LOCAL REPRODUCTION

Previous edition not usable

8. TO:

b. COMPANYa. NAME

c. STREET ADDRESS

d. CITY e. STATE f. ZIP CODE

9. DESTINATION

a. NAME OF CONSIGNEE

b. STREET ADDRESS

d. STATE e. ZIP CODE

7. DELIVERY

FOB DESTINATION

OTHER

(See Schedule)

10. PLEASE FURNISH QUOTATIONS TO THE

ISSUING OFFICE IN BLOCK 5a ON OR BEFORE CLOSE OF BUSINESS (Date)

IMPORTANT: This is a request for information and quotations furnished are not offers. If you are unable to quote, please so indicate on this form and return it to the address in Block 5a. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service. Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this Request for Quotation must be completed by the quoter.

11. SCHEDULE (Include applicable Federal, State and local taxes)

ITEM NUMBER

(a)

SUPPLIES/SERVICES

(b)

QUANTITY

(c)

UNIT

(d)

UNIT PRICE

(e)

AMOUNT

(f)

12. DISCOUNT FOR PROMPT PAYMENT

a. 10 CALENDAR DAYS (%) b. 20 CALENDAR DAYS (%) c. 30 CALENDAR DAYS (%) d. CALENDAR DAYS

NUMBER PERCENTAGE

NOTE: Additional provisions and representations are are not attached.

13. NAME AND ADDRESS OF QUOTER

a. NAME OF QUOTER

b. STREET ADDRESS

c. COUNTY

d. CITY e. STATE f. ZIP CODE

14. SIGNATURE OF PERSON AUTHORIZED TO

SIGN QUOTATION

PAGE OF PAGES

1. REQUEST NUMBER 2. DATE ISSUED 3. REQUISITION/PURCHASE REQUEST NUMBER 4. CERT. FOR NAT. DEF.

UNDER BDSA REG. 2

AND/OR DMS REG. 1

RATING

5a. ISSUED BY 6. DELIVER BY (Date)

NAME TELEPHONE NUMBER

AREA CODE NUMBER

c. CITY

5b. FOR INFORMATION CALL (NO COLLECT CALLS)

National Institutes of Health OD - Office of Logistics and Acquisition Operations 6100 Executive Blvd., Room 6B05 Bethesda, MD 20892-7511

75N98026Q01140

NICHOLAS CAPOBIANCO

+10

000-000000

09/03/2026

09/14/2026 1300 ED

Multiple

The purpose of this NON-COMPETITIVE

COMBINED SYNOPSIS / SOLICITATION is to provide NHLBI with EchoMRI-A130 Body

Composition Analyzer.

The following FAR clauses and Provisions are applicable to this award.

FAR 52.204-13 System for Award

Management Maintenance (Oct 2018);

FAR 52.204-18 Commercial and Government

Entity Code Maintenance (Aug 2020);

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity

Investigations (Dec 2015).

FAR 52.212-4 Contract Terms and

Continued...

1 7

CONTINUATION SHEET

REFERENCE NO. OF DOCUMENT BEING CONTINUED PAGES

NAME OF OFFEROR OR CONTRACTOR

SUPPLIES/SERVICES

(B)

UNIT

(D)

UNIT PRICE

(E)

AMOUNT

(F)

OPTIONAL FORM 336 (4-86)

Sponsored by GSA FAR (48 CFR) 53.110

ITEM NO.

(A)

QUANTITY

(C)

NSN 7540-01-152-8067

75N98026Q01140

Conditions -In addition to all the applicable commercial Products and Commercial Services

(Nov 2023)

FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE

NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION

Title: EchoMRI-A130 Body Composition Analyzer

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q01140. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a purchase order without providing for full and open competition (brand-name).

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a purchase order on a non-competitive basis to EchoMRI LLC, for the acquisition of one (1) EchoMRI-A130 body composition analyzer system to replace the aging EchoMRI unit currently in service at the NHLBI Mouse Phenotyping Core. EchoMRI LLC is the sole manufacturer of the EchoMRI-A130, which utilizes proprietary Quantitative Magnetic Resonance (QMR) technology protected by U.S.

Patents 7,366,560; 7,366,559; and 7,343,192. The EchoMRI-A130 is required to preserve continuity with 17-plus years of body composition data collected on the existing EchoMRI platform in support of ongoing intramural research protocols.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026.

(iv) The associated NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, and the small business size standard is 1,000 employees. This requirement is not set aside for small business.

(v) Description of Requirement:

The National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI), Mouse Phenotyping Core (MPC) requires one (1) EchoMRI-A130 system for the high-precision, non-invasive measurement of fat mass, lean mass, free water, and total body water in live mice with total body mass up to 130 g. The system shall include, at a minimum, the following salient characteristics:

• Quantitative Magnetic Resonance (QMR) measurement of fat mass, lean mass, free water, and total body water in conscious, unanesthetized live animals with total body mass up to 130 g, without exposure to ionizing radiation;

• EchoMRI specimen holders sized for 40 g, 60 g, and 80 g subjects;

• Daily system test and calibration samples;

• On-site installation and operator training;

• EchoMRI A10 insert antenna/probe for whole-organ and tissue-sample measurements;

• Independent reporting of free water and total body water as discrete parameters;

• Data output compatible with the MPC's existing EchoMRI dataset to preserve continuity of longitudinal research measurements.

(vi) Delivery Location:

National Institutes of Health Building 14F, Room 118 9000 Rockville Pike Bethesda, MD 20892

(vii) [Reserved]

(viii) FAR 52.204-7, System for Award Management, applies to this acquisition.

(ix) The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition.

(x) The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.

(a) A written notice of award or acceptance of an offer, issued to the successful offeror within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer (or part of an offer) before the expiration date, whether or not discussions are conducted, unless a written notice of withdrawal is received prior to award.

(xi) FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.

(xii) Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices: None.

(xiii) The Defense Priorities and Allocations System (DPAS) is not applicable to this requirement.

(xiv) Submission Requirements:

Responses must include sufficient information to demonstrate the respondent's capability to provide the required product or service. Price quotations shall include, at a minimum:

unit price, list price, shipping and handling costs, delivery timeframe after award, delivery terms, prompt payment discount terms, F.O.B. point (destination or origin), product or catalog numbers, product descriptions, and any other relevant information.

Evaluation factors may include, but are not limited to: past performance, technical capability, special features, trade-in considerations, expected lifecycle, warranty, maintenance availability, and environmental or energy efficiency considerations.

Respondents claiming to be manufacturers or authorized resellers of the specified brand-name product must provide:

(a) Product, catalog, model, and/or part number(s); (b) Product description; (c) Documentation demonstrating that the offered item meets all required salient characteristics identified in Section (v); (d) Quantity; (e) Estimated price or cost; (f) Shipping, handling, and/or installation charges; and (g) Delivery timeframe after receipt of order.

Responses must also include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.

All responses must be received by September 14, 2026, at 1:00 PM EDT and must reference solicitation number 75N98026Q01140. Responses may be submitted electronically to nicholas.capobianco@nih.gov.

(xv) Point of Contact:

Nicholas Capobianco Contracting Specialist National Institutes of Health Email:

nicholas.capobianco@nih.gov

Statement of Need (SON)

The Statement of Need is required for all product orders over $15,000. The statement describes the labs goals and how the purchase of the goods or services will advance those goals.

1. Project Title

EchoMRI-A130

2. Statement of Need and Objectives

The NHLBI Mouse Phenotyping Core (MPC) requires the EchoMRI-A130 system to measure lean mass, fat mass, free water, and total body water in live mice in support of intramural metabolic and cardiovascular research. The MPC's current EchoMRI unit is over 17 years old, is experiencing recurring hardware and computer-connectivity failures, and has reached the end of its serviceable life. Continued reliance on the aging system places active studies at risk of unplanned downtime, lost data, and compromised longitudinal datasets.

The EchoMRI-A130 uses quantitative magnetic resonance (QMR) to produce accurate, reproducible body composition measurements in conscious, unanesthetized animals in under two minutes per subject. Replacement with the A130 is necessary to:

• Maintain uninterrupted body composition phenotyping services for MPC investigators and their active protocols.

• Preserve the integrity and comparability of body composition data collected on the EchoMRI platform over the past 17 years, which is required for ongoing longitudinal studies and cross-study analyses.

• Support future metabolic and cardiovascular studies that depend on high-precision, non-invasive body composition measurement in mouse models with body masses ranging from neonatal to adult obese phenotypes (up to 130 g).

• Enable whole-organ and tissue-sample composition analysis via the EchoMRI A10 insert antenna/probe.

3. Product Specifications/Features/Salient Characteristics

The EchoMRI-A130 shall provide the following:

Title